Literature DB >> 23319473

The spectrum of nonmotor symptoms in early Parkinson disease.

Tien K Khoo1, Alison J Yarnall, Gordon W Duncan, Shirley Coleman, John T O'Brien, David J Brooks, Roger A Barker, David J Burn.   

Abstract

OBJECTIVE: Nonmotor symptoms (NMS) are common in patients with established Parkinson disease (PD) but their frequency in early PD has not been extensively studied. Our aim was to determine the frequency of NMS in a cohort of patients with newly diagnosed PD.
METHODS: A total of 159 patients with early PD and 99 healthy controls participated in this study. NMS were screened for using the nonmotor symptom questionnaire. Other assessments included measures of motor disability (Movement Disorders Society-revised unified Parkinson's disease rating scale [MDS-UPDRS]), disease severity (Hoehn & Yahr staging), depression (geriatric depression scale), and global cognitive function (Mini-mental state examination and Montreal cognitive assessment).
RESULTS: The PD group reported a significantly greater number of NMS compared with controls (8.4 [4.3] vs. 2.8 [2.6]). In the PD group, the most commonly experienced NMS were excessive saliva, forgetfulness, urinary urgency, hyposmia, and constipation. Patients with higher MDS-UPDRS III scores and those with the postural instability gait subtype experienced a greater number of NMS.
CONCLUSION: NMS are common in early PD and reflect the multisystem nature of the disorder. Even in the earliest stages of PD, NMS may be detrimental to patients' functional status and sense of well-being.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23319473      PMCID: PMC3589180          DOI: 10.1212/WNL.0b013e31827deb74

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  35 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders.

Authors:  Irene Litvan; Kailash P Bhatia; David J Burn; Christopher G Goetz; Anthony E Lang; Ian McKeith; Niall Quinn; Kapil D Sethi; Cliff Shults; Gregor K Wenning
Journal:  Mov Disord       Date:  2003-05       Impact factor: 10.338

3.  Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group.

Authors:  J Jankovic; M McDermott; J Carter; S Gauthier; C Goetz; L Golbe; S Huber; W Koller; C Olanow; I Shoulson
Journal:  Neurology       Date:  1990-10       Impact factor: 9.910

4.  Rapid eye movement sleep behavior disorder and subtypes of Parkinson's disease.

Authors:  Silvia Rios Romenets; Jean-Francois Gagnon; Véronique Latreille; Michel Panniset; Sylvain Chouinard; Jacques Montplaisir; Ronald B Postuma
Journal:  Mov Disord       Date:  2012-06-25       Impact factor: 10.338

5.  The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Authors:  Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow
Journal:  J Am Geriatr Soc       Date:  2005-04       Impact factor: 5.562

6.  Lewy body dysphagia.

Authors:  M Jackson; G Lennox; M Balsitis; J Lowe
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-06       Impact factor: 10.154

7.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

8.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

9.  What contributes to quality of life in patients with Parkinson's disease?

Authors:  A Schrag; M Jahanshahi; N Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

View more
  114 in total

Review 1.  Clinical Significance of REM Sleep Behavior Disorders and Other Non-motor Symptoms of Parkinsonism.

Authors:  Hong Jin; Jin-Ru Zhang; Yun Shen; Chun-Feng Liu
Journal:  Neurosci Bull       Date:  2017-08-03       Impact factor: 5.203

2.  Olfactory Function, Eating Ability, and Visceral Obesity Associated with MMSE Three Years after Parkinson's Disease Diagnosis.

Authors:  M Vikdahl; M E Domellöf; L Forsgren; L Håglin
Journal:  J Nutr Health Aging       Date:  2015-11       Impact factor: 4.075

3.  Time-dependent changes in postural control in early Parkinson's disease: what are we missing?

Authors:  Silvia Del Din; Alan Godfrey; Shirley Coleman; Brook Galna; Sue Lord; Lynn Rochester
Journal:  Med Biol Eng Comput       Date:  2015-06-07       Impact factor: 2.602

4.  Standard strategies for diagnosis and treatment of patients with newly diagnosed Parkinson disease: BRAZIL.

Authors:  Francisco Cardoso
Journal:  Neurol Clin Pract       Date:  2013-12

Review 5.  Microglial priming in neurodegenerative disease.

Authors:  V Hugh Perry; Clive Holmes
Journal:  Nat Rev Neurol       Date:  2014-03-18       Impact factor: 42.937

6.  Course of psychiatric symptoms and global cognition in early Parkinson disease.

Authors:  Patricia de la Riva; Kara Smith; Sharon X Xie; Daniel Weintraub
Journal:  Neurology       Date:  2014-08-15       Impact factor: 9.910

7.  Non-motor symptoms in Chinese Parkinson's disease patients with and without LRRK2 G2385R and R1628P variants.

Authors:  Da-Wei Li; Zhuqin Gu; Chaodong Wang; Jinghong Ma; Bei-Sha Tang; Sheng-Di Chen; Piu Chan
Journal:  J Neural Transm (Vienna)       Date:  2014-07-26       Impact factor: 3.575

8.  Mutant of leucine-rich repeat kinase 2 is not associated with non-motor symptoms in Chinese Parkinson's disease patients.

Authors:  Maolin Hao; Ning Pan; Qinghua Zhang; Xiaohong Wang
Journal:  Int J Clin Exp Med       Date:  2014-08-15

9.  "New methods of assessing autonomic disorders in Parkinson disease patients: skin-galvanic reaction".

Authors:  Justyna Dutkiewicz; Stanisław Szlufik; Andrzej Friedman
Journal:  J Neural Transm (Vienna)       Date:  2019-09-28       Impact factor: 3.575

Review 10.  Is there a need to redefine Parkinson's disease?

Authors:  Philipp Mahlknecht; Werner Poewe
Journal:  J Neural Transm (Vienna)       Date:  2013-05-29       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.